Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 120403084 | 12040308 | 4 | F | 20121207 | 20160621 | 20160208 | 20160705 | EXP | US-AUROBINDO-AUR-APL-2016-00947 | AUROBINDO | ANTIBACTERIALS/LISINOPRIL. REACTION WEEKLY. 2016;1584:26 | 69.00 | YR | F | Y | 0.00000 | 20160705 | PH | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 120403084 | 12040308 | 1 | PS | CEPHALEXIN. | CEPHALEXIN | 1 | Oral | U | U | 65253 | |||||||||
| 120403084 | 12040308 | 2 | SS | CEPHALEXIN. | CEPHALEXIN | 1 | U | U | 65253 | ||||||||||
| 120403084 | 12040308 | 3 | SS | HYDROCHLOROTHIAZIDE. | HYDROCHLOROTHIAZIDE | 1 | Unknown | Y | U | 0 | |||||||||
| 120403084 | 12040308 | 4 | SS | LISINOPRIL. | LISINOPRIL | 1 | Oral | 20 MG, ONCE A DAY (20 MG PO QD) | Y | U | 0 | 20 | MG | QD | |||||
| 120403084 | 12040308 | 5 | SS | ZOSYN | PIPERACILLIN SODIUMTAZOBACTAM SODIUM | 1 | Intravenous (not otherwise specified) | 3.375 G, EVERY 6 HOURS | Y | U | 0 | 3.375 | G | ||||||
| 120403084 | 12040308 | 6 | SS | Trimethoprim+Sulfamethoxazole | SULFAMETHOXAZOLETRIMETHOPRIM | 1 | Unknown | UNK | Y | U | 0 | ||||||||
| 120403084 | 12040308 | 7 | SS | Vancomycin | VANCOMYCIN | 1 | Intravenous (not otherwise specified) | 1 G, UNK | Y | U | 0 | 1 | G | ||||||
| 120403084 | 12040308 | 8 | SS | Vancomycin | VANCOMYCIN | 1 | Intravenous (not otherwise specified) | 750 MG, UNK | Y | U | 0 | 750 | MG | ||||||
| 120403084 | 12040308 | 9 | SS | Vancomycin | VANCOMYCIN | 1 | Intravenous (not otherwise specified) | 19 MCG/ML, UNK | Y | U | 0 | ||||||||
| 120403084 | 12040308 | 10 | SS | Vancomycin | VANCOMYCIN | 1 | Unknown | 4 G, UNK | Y | U | 0 | 4 | G | ||||||
| 120403084 | 12040308 | 11 | SS | Vancomycin | VANCOMYCIN | 1 | Intravenous (not otherwise specified) | 30.5 MCG/ML, UNK | Y | U | 0 | ||||||||
| 120403084 | 12040308 | 12 | SS | Vancomycin | VANCOMYCIN | 1 | Intravenous (not otherwise specified) | 23.1 MCG/ML, UNK | Y | U | 0 | ||||||||
| 120403084 | 12040308 | 13 | SS | Vancomycin | VANCOMYCIN | 1 | Unknown | 1 G, BID | Y | U | 0 | 1 | G | BID | |||||
| 120403084 | 12040308 | 14 | SS | Vancomycin | VANCOMYCIN | 1 | Intravenous (not otherwise specified) | 750 MG, BID | Y | U | 0 | 750 | MG | BID | |||||
| 120403084 | 12040308 | 15 | SS | Vancomycin | VANCOMYCIN | 1 | Unknown | 12 G, SINGLE | Y | U | 0 | 12 | G | ||||||
| 120403084 | 12040308 | 16 | SS | Vancomycin | VANCOMYCIN | 1 | Unknown | 4 G, SINGLE | Y | U | 0 | 4 | G | ||||||
| 120403084 | 12040308 | 17 | SS | Vancomycin | VANCOMYCIN | 1 | Intravenous (not otherwise specified) | 1 G, BID | Y | U | 0 | 1 | G | BID | |||||
| 120403084 | 12040308 | 18 | SS | Vancomycin | VANCOMYCIN | 1 | Intravenous (not otherwise specified) | 750 MG, BID | Y | U | 0 | 750 | MG | BID | |||||
| 120403084 | 12040308 | 19 | SS | Vancomycin | VANCOMYCIN | 1 | 12 G, SINGLE | Y | U | 0 | 12 | G | |||||||
| 120403084 | 12040308 | 20 | SS | Vancomycin | VANCOMYCIN | 1 | 4 G, SINGLE | Y | U | 0 | 4 | G | |||||||
| 120403084 | 12040308 | 21 | SS | ENALAPRIL | ENALAPRIL | 1 | Y | U | 0 | ||||||||||
| 120403084 | 12040308 | 22 | SS | AJ PIP/TAZ | PIPERACILLIN SODIUMTAZOBACTAM SODIUM | 1 | Intravenous (not otherwise specified) | UNK | Y | U | 0 | ||||||||
| 120403084 | 12040308 | 23 | SS | TOBRAMYCIN. | TOBRAMYCIN | 1 | Intravenous (not otherwise specified) | 10.8 G, UNK | 0 | 10.8 | G | ||||||||
| 120403084 | 12040308 | 24 | SS | TOBRAMYCIN. | TOBRAMYCIN | 1 | Intravenous (not otherwise specified) | 3.6 G, UNK | 0 | 3.6 | G | ||||||||
| 120403084 | 12040308 | 25 | SS | TOBRAMYCIN. | TOBRAMYCIN | 1 | Intravenous (not otherwise specified) | 5.8 MCG/ML, UNK | 0 | ||||||||||
| 120403084 | 12040308 | 26 | SS | TOBRAMYCIN. | TOBRAMYCIN | 1 | Intravenous (not otherwise specified) | 3.8 MCG/ML, UNK | 0 | ||||||||||
| 120403084 | 12040308 | 27 | SS | TOBRAMYCIN. | TOBRAMYCIN | 1 | 10.8 G, SINGLE | 0 | 10.8 | G | |||||||||
| 120403084 | 12040308 | 28 | SS | TOBRAMYCIN. | TOBRAMYCIN | 1 | 3.6 G, SINGLE | 0 | 3.6 | G | |||||||||
| 120403084 | 12040308 | 29 | SS | TOBRAMYCIN. | TOBRAMYCIN | 1 | 10.8 G, SINGLE | 0 | 10.8 | G | |||||||||
| 120403084 | 12040308 | 30 | SS | TOBRAMYCIN. | TOBRAMYCIN | 1 | 3.6 G, SINGLE | 0 | 3.6 | G | |||||||||
| 120403084 | 12040308 | 31 | C | DULOXETINE. | DULOXETINE | 1 | Unknown | UNK | U | 0 | |||||||||
| 120403084 | 12040308 | 32 | C | SOLIFENACIN | SOLIFENACIN | 1 | Unknown | U | 0 | ||||||||||
| 120403084 | 12040308 | 33 | C | AMLODIPINE | AMLODIPINE BESYLATE | 1 | Unknown | U | 0 | ||||||||||
| 120403084 | 12040308 | 34 | C | ACETAMINOPHENHYDROCODONE BITARTRATE | ACETAMINOPHENHYDROCODONE BITARTRATE | 1 | Unknown | U | 0 | ||||||||||
| 120403084 | 12040308 | 35 | C | MORPHINE | MORPHINE | 1 | Unknown | U | 0 | ||||||||||
| 120403084 | 12040308 | 36 | C | PAROXETINE. | PAROXETINE | 1 | Unknown | U | 0 | ||||||||||
| 120403084 | 12040308 | 37 | C | RIFAMPIN. | RIFAMPIN | 1 | Oral | U | 0 | ||||||||||
| 120403084 | 12040308 | 38 | C | DAPTOMYCIN. | DAPTOMYCIN | 1 | Intravenous (not otherwise specified) | U | U | 0 | |||||||||
| 120403084 | 12040308 | 39 | C | RIFAMPICIN | RIFAMPIN | 1 | UNK | U | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 120403084 | 12040308 | 1 | Pain |
| 120403084 | 12040308 | 2 | Swelling |
| 120403084 | 12040308 | 3 | Product used for unknown indication |
| 120403084 | 12040308 | 4 | Hypertension |
| 120403084 | 12040308 | 5 | Product used for unknown indication |
| 120403084 | 12040308 | 6 | Product used for unknown indication |
| 120403084 | 12040308 | 7 | Product used for unknown indication |
| 120403084 | 12040308 | 21 | Product used for unknown indication |
| 120403084 | 12040308 | 22 | Product used for unknown indication |
| 120403084 | 12040308 | 23 | Knee arthroplasty |
| 120403084 | 12040308 | 31 | Product used for unknown indication |
| 120403084 | 12040308 | 32 | Product used for unknown indication |
| 120403084 | 12040308 | 33 | Product used for unknown indication |
| 120403084 | 12040308 | 34 | Product used for unknown indication |
| 120403084 | 12040308 | 35 | Product used for unknown indication |
| 120403084 | 12040308 | 36 | Product used for unknown indication |
| 120403084 | 12040308 | 37 | Product used for unknown indication |
| 120403084 | 12040308 | 38 | Product used for unknown indication |
| 120403084 | 12040308 | 39 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 120403084 | 12040308 | HO |
| 120403084 | 12040308 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 120403084 | 12040308 | Acute kidney injury | |
| 120403084 | 12040308 | Arthritis bacterial | |
| 120403084 | 12040308 | Blood pressure decreased | |
| 120403084 | 12040308 | Drug clearance decreased | |
| 120403084 | 12040308 | Haemoglobin increased | |
| 120403084 | 12040308 | Hypotension | |
| 120403084 | 12040308 | Renal tubular necrosis |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |